Connor, Clark & Lunn Investment Management Ltd.
Position in ZTS — Zoetis Inc.
CIK 1596800
VANCOUVER, A1
Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,514,763
-$13,629,398 QoQ
Shares Held
118,491
-36.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#263
of 1,408 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
572,598 | $36,617,642 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
721,002 | $12,949,195 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
118,491 | $8,514,763 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,811,714 | $7,627,315 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
192,766 | $6,530,911 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
231,979 | $3,361,375 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
353,983 | $2,966,377 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
95,381 | $2,347,326 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,514,763 | 118,491 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,144,161 | 187,329 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $42,949,034 | 341,353 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $53,984,764 | 368,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $29,299,106 | 187,875 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $8,709,586 | 53,456 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $84,132,128 | 485,303 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $91,671,209 | 541,760 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $17,865,537 | 90,518 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,327,067 | 53,610 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $471,744 | 3,219 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $294,652 | 1,987 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $385,549 | 2,243 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,066,192 | 10,956 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $219,871 | 901 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $26,771,906 | 137,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $39,132,618 | 209,984 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $37,009,217 | 235,009 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $23,403,851 | 141,413 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,366,699 | 74,782 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $2,761,948 | 23,468 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||